Table 3.
Variable | KIF20A expression
|
|
---|---|---|
Spearman’s correlation coefficient | P-value | |
Age | 0.016 | 0.842 |
Histological type | –0.54 | 0.518 |
FIGO stage | 0.291 | 0.001 |
Intraperitoneal metastasis | 0.354 | <0.001 |
Lymph node metastasis | 0.269 | 0.002 |
Intestinal metastasis | 0.091 | 0.286 |
Vital status at last follow-up | 0.475 | <0.001 |
Tumor recurrence | 0.231 | 0.005 |
Intraperitoneal recurrence | 0.218 | 0.030 |
Distant recurrence | –0.079 | 0.554 |
Residual tumor size (cm) | 0.064 | 0.471 |
Differentiation grade | –0.029 | 0.745 |
Neoadjuvant chemotherapy | 0.152 | 0.064 |
Postoperative chemotherapy | –0.029 | 0.726 |
HIPEC | 0.106 | 0.216 |
Ascites with tumor cells | 0.377 | <0.001 |
Cytoreductive surgery | –0.014 | 0.861 |
Drug resistance | 0.329 | 0.012 |
CA125 (U/mL) | –0.049 | 0.572 |
CA199 (U/mL) | –0.125 | 0.149 |
CA153 (U/mL) | 0.112 | 0.226 |
NSE (U/mL) | –0.110 | 0.319 |
CEA (U/mL) | 0.142 | 0.134 |
β-HCG (U/mL) | 0.003 | 0.978 |
Abbreviations: β-HCG, β human choriogonadotropin; CEA, carcinoembryonic antigen; FIGO, International Federation of Gynecology and Obstetrics stage; HIPEC, hyperthermic intraperitoneal chemotherapy; NSE, neuron-specific enolase.